Literature DB >> 27109036

A reliable method for avoiding false negative results with Luminex single antigen beads; evidence of the prozone effect.

B Sean Carey1, Kim Boswijk2, Mazen Mabrok2, Peter A Rowe3, Andrew Connor3, Imran Saif3, Anthony Poles4.   

Abstract

Luminex single antigen bead (SAB) assays have become an essential tool in monitoring the status of antibody to the Human Leucocyte Antigen (HLA) of patients both before and after transplantation. In addition SAB data is used to aid risk stratification to assess immunological risk of humoral rejection in solid organ transplantation (CTAG/BTAG guidelines) [1]. Increasingly laboratories are reporting false negative results at high antibody titre due to a prozone effect. Here we report a case study where the prozone effect led to a false negative antibody result that could have resulted in adverse outcome. We describe a method to reliably remove the prozone effect through heat inactivation and the addition of Ethylenediaminetetraacetic acid (EDTA) to the Luminex wash buffer.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Donor specific antibody; False negative; HLA antibody; Prozone; Single antigen bead assay

Mesh:

Substances:

Year:  2016        PMID: 27109036     DOI: 10.1016/j.trim.2016.04.002

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  3 in total

Review 1.  Detection of HLA Antibodies in Organ Transplant Recipients - Triumphs and Challenges of the Solid Phase Bead Assay.

Authors:  Brian D Tait
Journal:  Front Immunol       Date:  2016-12-09       Impact factor: 7.561

2.  Quantitative Evaluation of the Impact of Ethylenediaminetetraacetic Acid Pretreatment on Single-Antigen Bead Assay.

Authors:  Chang Liu; Sue Pang; Donna Phelan; Daniel C Brennan; Thalachallour Mohanakumar
Journal:  Transplant Direct       Date:  2017-07-11

3.  Photocleavage-based affinity purification of biomarkers from serum: Application to multiplex allergy testing.

Authors:  Zhi Wan; Heather P Ostendorff; Ziying Liu; Lynda C Schneider; Kenneth J Rothschild; Mark J Lim
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.